Korneuburg, Austria, 20. January 2025 – Marinomed Biotech AG (VSE:MARI) announces that the restructuring proceedings without self-administration opened on August 14th, 2024, have been formally completed by resolution of the Korneuburg regional court on January 14th, 2025. In December, the Company met all necessary prerequisites, including depositing the funds required for payment of the cash quota and the costs of the proceedings. With the formal end of the proceedings, administration by the insolvency administrator has also ended and the Management Board has regained control over the Company.
Restructuring administrator
Dr. Ulla Reisch
Landstr. Hauptstr. 1a,Level 07,Top 09
1030 Vienna
Tel.: 01212 55 00, Fax: 01/212 55 00-5
E-mail: office.wien@ulsr.at
Find here all relevant press releases and ad-hoc announcements:
